Company’s 36-month beta value is 4.24.Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for BHVN is 70.07M, and currently, short sellers hold a 12.32% ratio of that floaft. The average trading volume of BHVN on April 12, 2024 was 1.14M shares.
BHVN) stock’s latest price update
The stock price of Biohaven Ltd (NYSE: BHVN) has jumped by 4.76 compared to previous close of 51.06. Despite this, the company has seen a gain of 2.22% in its stock price over the last five trading days. CNBC Television reported 2024-03-25 that Vlad Coric, Biohaven CEO, joins ‘Fast Money’ to discuss the weight loss drug wars and the company’s experimental obesity drug.
BHVN’s Market Performance
Biohaven Ltd (BHVN) has experienced a 2.22% rise in stock performance for the past week, with a -8.69% drop in the past month, and a 15.03% rise in the past quarter. The volatility ratio for the week is 4.53%, and the volatility levels for the past 30 days are at 5.10% for BHVN.. The simple moving average for the past 20 days is -2.36% for BHVN’s stock, with a 56.82% simple moving average for the past 200 days.
Analysts’ Opinion of BHVN
Many brokerage firms have already submitted their reports for BHVN stocks, with RBC Capital Mkts repeating the rating for BHVN by listing it as a “Outperform.” The predicted price for BHVN in the upcoming period, according to RBC Capital Mkts is $62 based on the research report published on February 16, 2024 of the current year 2024.
UBS, on the other hand, stated in their research note that they expect to see BHVN reach a price target of $59. The rating they have provided for BHVN stocks is “Buy” according to the report published on February 06th, 2024.
H.C. Wainwright gave a rating of “Buy” to BHVN, setting the target price at $50 in the report published on December 22nd of the previous year.
BHVN Trading at 3.56% from the 50-Day Moving Average
After a stumble in the market that brought BHVN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -14.02% of loss for the given period.
Volatility was left at 5.10%, however, over the last 30 days, the volatility rate increased by 4.53%, as shares sank -10.48% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +22.10% upper at present.
During the last 5 trading sessions, BHVN rose by +2.22%, which changed the moving average for the period of 200-days by +136.68% in comparison to the 20-day moving average, which settled at $54.47. In addition, Biohaven Ltd saw 24.98% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BHVN starting from Antonijevic Irina, who sale 11,000 shares at the price of $41.79 back on Dec 29 ’23. After this action, Antonijevic Irina now owns 2,535 shares of Biohaven Ltd, valued at $459,662 using the latest closing price.
CHILDS JOHN W, the Director of Biohaven Ltd, purchase 454,545 shares at $22.00 during a trade that took place back on Oct 05 ’23, which means that CHILDS JOHN W is holding 3,998,952 shares at $9,999,990 based on the most recent closing price.
Stock Fundamentals for BHVN
The total capital return value is set at -0.95. Equity return is now at value -84.44, with -69.48 for asset returns.
Based on Biohaven Ltd (BHVN), the company’s capital structure generated 0.07 points at debt to capital in total, while cash flow to debt ratio is standing at -10.74. The debt to equity ratio resting at 0.07. The interest coverage ratio of the stock is 52.99.
Currently, EBITDA for the company is -432.68 million with net debt to EBITDA at 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.98.
Conclusion
In a nutshell, Biohaven Ltd (BHVN) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
